
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14482621
[patent_doc_number] => 10328069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Phosphatidylinositol 3-kinase inhibitors for the treatment of lymphoproliferative malignancies
[patent_app_type] => utility
[patent_app_number] => 15/600147
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11157
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600147
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600147 | Phosphatidylinositol 3-kinase inhibitors for the treatment of lymphoproliferative malignancies | May 18, 2017 | Issued |
Array
(
[id] => 12057087
[patent_doc_number] => 20170333430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/585523
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 20691
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585523
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/585523 | COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS | May 2, 2017 | Abandoned |
Array
(
[id] => 12113012
[patent_doc_number] => 09868994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Methods of stratifying patients for treatment with retinoic acid receptor-α agonists'
[patent_app_type] => utility
[patent_app_number] => 15/582311
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 24992
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15582311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/582311 | Methods of stratifying patients for treatment with retinoic acid receptor-α agonists | Apr 27, 2017 | Issued |
Array
(
[id] => 14273427
[patent_doc_number] => 20190133998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => TREATMENT OF TUMORS WITH INHIBITORS OF CXCL12 SIGNALING AND SUBTHERAPEUTIC AMOUNTS OF CHEMOTHERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/096995
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096995
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096995 | TREATMENT OF TUMORS WITH INHIBITORS OF CXCL12 SIGNALING AND SUBTHERAPEUTIC AMOUNTS OF CHEMOTHERAPEUTIC AGENTS | Apr 25, 2017 | Abandoned |
Array
(
[id] => 17586465
[patent_doc_number] => 11324706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Composition for inhibiting growth of breast cancer stem cells containing phenylacetaldehyde
[patent_app_type] => utility
[patent_app_number] => 16/097307
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 26
[patent_no_of_words] => 11439
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097307 | Composition for inhibiting growth of breast cancer stem cells containing phenylacetaldehyde | Apr 24, 2017 | Issued |
Array
(
[id] => 11850188
[patent_doc_number] => 20170224681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'METHOD OF TREATING BIPOLAR I AND II DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/494877
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4738
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494877
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/494877 | METHOD OF TREATING BIPOLAR I AND II DISORDERS | Apr 23, 2017 | Abandoned |
Array
(
[id] => 11834529
[patent_doc_number] => 20170216249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth'
[patent_app_type] => utility
[patent_app_number] => 15/487036
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11823
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487036
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487036 | Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth | Apr 12, 2017 | Abandoned |
Array
(
[id] => 14306163
[patent_doc_number] => 20190142785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => Compound that Inhibits Binding of Influenza-Virus PB Subunit to RNA Cap
[patent_app_type] => utility
[patent_app_number] => 16/093529
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093529
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093529 | Inhibiting binding of influenza-virus PB2 subunit to RNA cap | Apr 11, 2017 | Issued |
Array
(
[id] => 12029157
[patent_doc_number] => 20170319256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'METHOD OF SELECTIVELY KILLING CANCER CELLS USING LOW-TEMPERATURE PLASMA JET DEVICE AND METHOD OF TREATING TUMORS USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/478558
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 5382
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478558
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/478558 | METHOD OF SELECTIVELY KILLING CANCER CELLS USING LOW-TEMPERATURE PLASMA JET DEVICE AND METHOD OF TREATING TUMORS USING THE SAME | Apr 3, 2017 | Abandoned |
Array
(
[id] => 11757206
[patent_doc_number] => 20170204073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/475240
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 48872
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15475240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/475240 | COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE | Mar 30, 2017 | Abandoned |
Array
(
[id] => 14210545
[patent_doc_number] => 20190117657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => METHOD OF INHIBITING HIGH FAT DIET-RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/089637
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089637
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089637 | METHOD OF INHIBITING HIGH FAT DIET-RELATED CONDITIONS | Mar 30, 2017 | Abandoned |
Array
(
[id] => 14182645
[patent_doc_number] => 20190111027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => COMPOSITION FOR CONTROLLING MICROSPORIDIA IN FISHES AND METHOD FOR CONTROLLING MICROSPORIDIA IN FISHES USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/089226
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 384
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089226 | Composition for controlling microsporidia in fishes and method for controlling microsporidia in fishes using same | Mar 29, 2017 | Issued |
Array
(
[id] => 17250051
[patent_doc_number] => 11185519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => Methods of treatment of cholestatic diseases
[patent_app_type] => utility
[patent_app_number] => 16/090415
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5884
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090415 | Methods of treatment of cholestatic diseases | Mar 29, 2017 | Issued |
Array
(
[id] => 11742799
[patent_doc_number] => 20170196870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING ULCERATIVE COLITIS'
[patent_app_type] => utility
[patent_app_number] => 15/471745
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12335
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471745 | Pharmaceutical composition for treating ulcerative colitis | Mar 27, 2017 | Issued |
Array
(
[id] => 11742789
[patent_doc_number] => 20170196861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE'
[patent_app_type] => utility
[patent_app_number] => 15/471334
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10075
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471334 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile | Mar 27, 2017 | Issued |
Array
(
[id] => 14210503
[patent_doc_number] => 20190117636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES
[patent_app_type] => utility
[patent_app_number] => 16/089316
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089316
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089316 | 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES | Mar 27, 2017 | Abandoned |
Array
(
[id] => 14069251
[patent_doc_number] => 20190083513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHODS OF TREATING VITAMIN D INSUFFICIENCY IN CHRONIC KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/089235
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089235
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089235 | Methods of treating vitamin D insufficiency in chronic kidney disease | Mar 27, 2017 | Issued |
Array
(
[id] => 12111838
[patent_doc_number] => 09867815
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-01-16
[patent_title] => 'Pharmaceutical compositions and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 15/470133
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 23
[patent_no_of_words] => 33467
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470133
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470133 | Pharmaceutical compositions and methods of using the same | Mar 26, 2017 | Issued |
Array
(
[id] => 12043373
[patent_doc_number] => 09820957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Methods of treating autoimmunity'
[patent_app_type] => utility
[patent_app_number] => 15/466026
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 7586
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15466026
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/466026 | Methods of treating autoimmunity | Mar 21, 2017 | Issued |
Array
(
[id] => 11962050
[patent_doc_number] => 20170266204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'ONAPRISTONE METABOLITE COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/464085
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5444
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15464085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/464085 | ONAPRISTONE METABOLITE COMPOSITIONS AND METHODS | Mar 19, 2017 | Abandoned |